Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3679912019 | Hydralazine 37.5 mg and isosorbide dinitrate 20 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3679913012 | Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing hydralazine and isosorbide dinitrate (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Osmotic diuretic (substance) | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Hydralazine (substance) | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Isosorbide dinitrate (substance) | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has manufactured dose form | Oral tablet | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Hydralazine-containing product in oral dose form | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing isosorbide dinitrate in oral dosage form | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Hydralazine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Hydralazine (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 37.5 | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has active ingredient | Isosorbide dinitrate (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Isosorbide dinitrate (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 20 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | mg | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Isosorbide dinitrate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 20 (kwalificatiewaarde) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has basis of strength substance (attribute) | Hydralazine (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 37.5 | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydralazine (substance) | false | Inferred relationship | Some | 2 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has precise active ingredient | Isosorbide dinitrate (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing hydralazine and isosorbide in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Nitrogen and/or nitrogen compound-containing product | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing precisely hydralazine 37.5 milligram and isosorbide dinitrate 20 milligram/1 each conventional release oral tablet | Is a | Product containing only hydralazine and isosorbide in oral dose form (medicinal product form) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)
FHIR